Article
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
PLoS genetics - 1 Jun 2011
Freedman Barry I, Langefeld Carl D, Lu Lingyi, Divers Jasmin, Comeau Mary E, Kopp Jeffrey B, Winkler Cheryl A, Nelson George W, Johnson Randall C, Palmer Nicholette D, Hicks Pamela J, Bostrom Meredith A, Cooke Jessica N, McDonough Caitrin W, Bowden Donald W
Abstract excerpt
Single nucleotide polymorphisms (SNPs) in MYH9 and APOL1 on chromosome 22 (c22) are powerfully associated with non-diabetic end-stage renal disease (ESRD) in African Americans (AAs). Many AAs diagnosed with type 2 diabetic nephropathy (T2DN) have non-diabetic kidney disease, potentially masking detection of DN genes. Therefore, genome-wide association analyses were performed using the Affymetrix SNP Array 6.0 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
